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Abstract 
This study investigated the difference between concurrent and simultaneous use of alcohol and 
non-medical use of prescription drugs (NMUPD) in relation to mental, social, and health issues. 
The 544 study participants of the Swiss ongoing Cohort Study on Substance Use Risk Factors 
(C-SURF) had a combined use of alcohol with NMUPD during the previous 12 months. 
Alcohol-related problems (i.e., dependence and consequences), as well as mental, social, and 
health concerns (i.e., depression, general mental/physical health, and social/health 
consequences), were assessed. The simultaneous use of alcohol and NMUPD proved to be a 
greater risk factor for mental, social, and health issues than concurrent use. This study adds 
essential information regarding simultaneous polydrug use, which results in distinct effects 
compared to concurrent use, including important social, psychosocial, and health-related 
consequences. 
 
Keywords: alcohol use; concurrent use; non-medical use of prescription drugs; simultaneous use 
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INTRODUCTION 
Non-medical use of prescription drugs (NMUPD) is on the rise (Catalano et al. 2011; Grant et al. 
2004; Rigg and Ibañez 2010) and has been shown to produce important detrimental effects, 
including mood and psychiatric disorders, accidental overdoses, and/or physical problems 
(Blanco et al. 2007; Davis and Johnson 2008; Ghandour, El Sayed, and Martins 2012; Huang et 
al. 2006; McCabe and Boyd 2005; McCabe, Cranford, and West 2008; Zullig and Divin 2012). 
In addition, some studies have reported the negative consequences of combining NMUPD with 
alcohol use (Barrett and Pihl 2002; Koski, Ojanperä, and Vuori 2002; Sellers et al. 1993; 
Sheehan et al. 1991; Watson et al. 2004). However, only a limited number of studies have 
focused on the differences between simultaneous and concurrent use of alcohol and NMUPD, 
even though alcohol may have important modifying or amplifying effects on prescription drugs. 
Therefore, this study investigated the effects and differences in these uses. 
“Concurrent use” describes the use of alcohol and NMUPD within a given time period but not 
necessarily at the same time (Earleywine and Newcomb 1997), whereas “simultaneous use” 
refers to the use of these substances at the same time, on a single occasion (Martin 2008). Indeed, 
simultaneous use has been associated with more detrimental effects in comparison to concurrent 
polydrug use, including social, psychosocial, and health-related consequences (Martin 2008; 
Midanik, Tam, and Weisner 2007), as well as drug use-related problems (McCabe et al. 2006). 
For alcohol and NMUPD co-use, it was reported that simultaneous use of alcohol and ADHD 
prescription stimulants was associated with increased alcohol-related consequences, increased 
substance use, and lower academic performance (Egan et al. 2013). However, this study focused 
on one kind of NMUPD only. It was also demonstrated that college students engaging in 
simultaneous use of alcohol and NMUPD were more likely to report frequent binge drinking 
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(McCabe and Boyd 2005) and negative consequences (Hermos et al. 2009; McCabe, Cranford, 
and Boyd 2006; McCabe et al. 2006) than those engaging in concurrent use. Nevertheless, issues 
with other substances and consequences remain understudied. For example, to our knowledge, 
no study has described the association of simultaneous use with mental issues such as 
depression, health issues, or with social issues other than academic failure. 
Therefore, the aim of this study was to investigate the relationship between patterns of alcohol 
and NMUPD co-use (i.e., simultaneous versus concurrent use) and mental, social, and health 
issues. 
 
METHODS 
Participants 
The data are part of the Cohort Study on Substance Use Risk Factors (C-SURF), a study 
designed to assess substance use patterns and their related consequences in young Swiss men. 
Participant enrollment took place between August 23rd 2010 and November 15th 2011 in 3 out of 
6 army recruitment centers covering 21 of 26 cantons in Switzerland, including all French-
speaking cantons. There was no pre-selection for this conscription, and all young men around 20 
years-old were evaluated to determine their eligibility for military, civil, or no service. Thus, all 
young Swiss men around 20 years-old were eligible for study inclusion. The recruitment centers 
were only used to enroll participants. Assessment was carried out outside of the army 
environment and independently of eligibility for military service. 
Of the 13,245 conscripts informed about the study, 7,563 gave written consent to participate 
(57.1%), and 5,990 filled in the baseline questionnaire (79.2%). The present study focused on the 
580 participants who had used both alcohol and NMUPD during the previous 12 months (9.7% 
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of the sample). Missing values were likewise deleted, ultimately resulting in 544 total 
participants (93.8% of the alcohol and NMUPD users). More information about the sampling and 
non-responses can be found elsewhere (Studer et al., 2013), including comparisons between 
respondents and non-respondents, because all conscripts filled in an anonymous five-minute 
questionnaire. In short, non-respondents were more likely to be substance users, but the non-
response bias was small. Participants were more often German-speaking, had a higher level of 
education, and were older, but effect sizes were negligible (≈ .10 for language and education, < 
.01 for age). 
 
Measures 
Concurrent and simultaneous use of alcohol and NMUPD. Participants were asked if they had 
used alcohol along with NMUPD during the previous 12 months. The response to this question 
was based on a 6-point scale (“all the time”, “most of the time”, “half of the time”, “seldom”, 
“hardly ever”, or “never”). Participants who answered “hardly ever” and “never” were recorded 
as concurrent users, whereas all others were considered simultaneous users. 
Alcohol. For the previous 12 months, alcohol dependence was assessed with the seven criteria of 
alcohol dependence from the Diagnostic and Statistical Manual of Mental Disorders (DSM IV) 
as in Knight et al. (2002). We used a continuous numbered scale of the seven criteria (from 0 to 
7), instead of a cut-off, because current literature assumes a more continuous dimensional 
construct to alcohol dependence rather than a categorical model (Knight et al. 2002; Kerridge et 
al. 2013). 
Nine alcohol-related consequences (i.e., drank/took medicine to get over a bad secondary effect, 
mental blackout, did something badly regretted later, unplanned sex, sex without a condom, 
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accident/injury, conflict with police/authorities more than once, argument/fight, and damaged 
property) were assessed and coded “0” if it had not taken place in the previous 12 months and 
“1” if it had occurred at least once. A sum score was then computed (0–9). 
In addition, the quantity and frequency of alcohol use during the previous 12 months were 
assessed (i.e., average number of days per week in which alcohol was consumed and number of 
standard drinks consumed during those drinking days). The weekly volume of drinking was 
subsequently determined by multiplying the number of drinking days by the usual number of 
drinks on these days. 
NMUPD. The frequency of NMUPD was assessed by inquiring how often participants used six 
types of prescription drugs (sleeping pills, anxiolytics, painkillers [excluding over the counter 
painkillers], antidepressants, stimulants, and beta-blockers) during the previous 12 months. The 
question dealt only with non-medical use (i.e., by choice, without a doctor’s prescription or for a 
reason other than a doctor’s prescription). Participants answered on an ordinal 8-point scale for 
each type of prescription drug (“never”, “once a year”, “2–3 time a year”, “4–9 times a year”, 
“1–2 times a month”, “3–4 times a month”, “2–3 times a week”, and “4 times per week or 
more”). A global score for the annual use of any prescription drug was computed, converting the 
ordinal scale into the corresponding number of days. 
Depression. The Major Depressive Inventory was used to determine depression level (Bech et al. 
2001; Olsen et al. 2003). This 10-item mood questionnaire allowed assessment for the presence 
of a depressive disorder according to the DSM-IV and included items such as “Have you felt low 
in spirits or sad?” and “Have you felt subdued or slowed down?”. Responses were given on a 6-
point scale from “never” (0) to “all the time” (5). A sum score related to depression was 
computed based on the participants’ answers. In order to better capture the variability in the 
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range of depression symptoms, a continuous scale (ranging from 0 to 50) was used instead of a 
specific cut-off value. 
Mental and physical health. Physical and mental health were assessed using the Short Form 
Health Survey (SF-12 version 2) (Ware, Kosinski, and Keller 1996), which contained two 
subscales: mental health composite scale and physical health composite scale. The subscales 
were computed according to a standard scoring procedure, giving two composite scores ranging 
from 0 (health problem) to 100 (no health problem) with a standardized mean of 50. 
Consequences. Sixteen consequences, which were not explicitly substance related (Gmel et al. 
2012), were selected from standard instruments (Bucholz et al. 1994; Hesselbrock et al. 1999; 
Hibell et al. 2012; Wechsler et al. 1994). Consequences were coded as “0” if they did not take 
place in the past 12 months and “1” if they had occurred at least once during the past 12 months. 
Two sum scores were computed: the first was for social consequences (i.e., physical fight, 
problems with family, problems with friends, poor performance at school/work, theft, trouble 
with police, regret over sexual intercourse, sexual intercourse without a condom, and damaged 
property), and the second was related to health consequences (i.e., accident/injury, admittance to 
an emergency room, attempted suicide, requirement for medical treatment, night spent in the 
hospital, outpatient surgery, and treatment in an emergency room because of an accident/injury). 
Additional variables. We controlled for social and demographic variables that may influence 
young adults’ substance use. These included age, language (French- or German-speaking), level 
of education (lower secondary, upper secondary, or tertiary), parents’ level of education (lower 
secondary, upper secondary, or tertiary), perceived family income (“below-average income”, 
“average income”, or “above-average income”), and illicit drug use (coded 1 if participants used 
at least one illicit drug during the previous 12 months and 0 otherwise). 
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 Statistical analyses 
Descriptive statistics were computed in order to explore the prevalence rates associated with 
concurrent and simultaneous use of alcohol and NMUPD. 
Concurrent and simultaneous users were then compared with 7 Generalized Linear Models 
(GLM) for linear (mental and physical health composite scores) and count (alcohol dependence, 
alcohol-related consequences, depression, health-related consequences, and social consequences) 
outcomes. All models were performed controlling for drinking volume, annual frequency of 
NMUPD, illicit drug use, age, linguistic region, level of education, parents’ level of education, 
and perceived family income. Holm–Bonferroni correction (Holm 1979) was used to keep a 
significance threshold of p < .05. 
 
RESULTS 
The participants (mean age: 20.10 years old, SD = 1.37) who used both alcohol and NMUPD 
during the previous 12 months consisted mainly of concurrent users of the two substances (Table 
1). Indeed, only 11.6% of the participants were simultaneous users. In the previous 12 months, 
the participants drank 11.04 weekly alcoholic drinks on average and engaged in NMUPD 34.71 
times. Bivariate comparisons between concurrent and simultaneous users showed that 
simultaneous users reported more drug use and more mental, social, and health issues. 
 
Insert Table 1 about here 
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GLM indicated significant differences between the simultaneous and concurrent users (Table 2). 
Indeed, simultaneous users reported more of the following: alcohol dependence (concurrent users 
[CU]: 1.12, simultaneous users [SU]: 1.92 , p < .001), alcohol-associated issues (CU: 1.71, SU: 
2.50, p < .001), depression (CU: 10.25, SU: 19.17, p < .001), mental health issues (CU: 44.03, 
SU: 39.44, p = .006), physical health issues (CU: 52.22, SU: 48.87 p < .001), health-related 
consequences (CU: 1.89, SU: 2.39, p = .011), and social consequences (CU: 2.70, SU: 3.51, p = 
.007). 
 
Insert Table 2 about here 
 
DISCUSSION 
This study investigated the differences between simultaneous and concurrent use of alcohol and 
NMUPD in relation to mental, social, and health issues. The results indicated that the 
simultaneous use of alcohol and NMUPD was associated with more detrimental issues than 
concurrent use, beyond socio-demographic substance use-related risk factors. We observed more 
alcohol-related problems (i.e., dependence and consequences; previously shown in Egan et al. 
2012; McCabe et al. 2006), as well as increases in mental, physical, social, and health issues. 
Therefore, the findings are in agreement with other studies dealing with substances other than 
alcohol and NMUPD that have reported that simultaneous polydrug use is associated with more 
social consequences, psychosocial distress, and health problems than concurrent use (Martin 
2008; Midanik, Tam, and Weisner 2007). Our results are particularly interesting because they 
concern legal drugs (i.e., alcohol and prescription drugs) that are widely used and easily 
available, especially in the case of alcohol. The observed effect sizes were lower for health-
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related problems (mental and physical health, health consequences; partial η2: 2–3%) compared 
to other consequences (social and alcohol-associated issues, depression or alcohol dependence; 
partial η2: 6–8%). 
Pharmacological studies have demonstrated that alcohol (ethanol) may enhance the effect of 
prescription drugs by increasing the bioavailability of stimulants (e.g., amphetamines) (Egan et 
al. 2012), augmenting the abuse liability-related subjective effects of prescription opioids 
(McCabe et al. 2012) and/or reducing the negative effects of alcohol (Egan et al. 2012). These 
factors might encourage the simultaneous use of alcohol and NMUPD. Although only a minority 
of the young Swiss men simultaneously used alcohol and NMUPD (21.5% of the subsample of 
alcohol and NMUPD co-users), this pattern of use may represent a major health concern due to 
the harmful effects, desirable pharmacological properties, and growing use of NMUPD. 
 
This study has some limitations. In particular, the cross-sectional design did not allow us to 
investigate the causal relationship between simultaneous polydrug use and mental, social, or 
health issues. However, an upcoming follow-up of the C-SURF cohort will allow the study of the 
effect of previous drug co-use on later issues. A second limitation of this study relates to the 
exclusion of women. Therefore, a similar association study will need to be carried out to 
determine if these results are applicable to women who simultaneously use alcohol and NMUPD. 
One last shortcoming was that the data were self-reported. This could have introduced various 
forms of bias, including recall bias, pressure to give desirable answers, and non-response bias. 
However, self-reported data on risky behaviors and substance use are generally considered valid 
(Ford, 2008). 
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To conclude, this study identified patterns of alcohol and NMUPD use that are associated with 
increased vulnerability. We demonstrated that simultaneous use of alcohol and NMUPD was 
associated with more mental, social, and health issues than concurrent use of these substances. 
Our findings are particularly important because they concern legal substances that are often 
easily available, particularly in the case of alcohol. In addition, while simultaneous use of these 
substances may be encouraged due to enhanced effects, there are many detrimental consequences 
that need to be considered. This information will be valuable for healthcare, suggesting the need 
to take into account patterns of alcohol and NMUPD co-use for intervention and preventive 
programs. 
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      Overall Concurrent users Simultaneous users 
N (%) 544 486 (88.4%) 64 (11.6%) 
Drug use 
 
  
 
Weekly volume of drinking1 11.04 (23.34) 9.13 (12.57) 25.6” (57.48) 
 
Annual frequency of NMUPD1 34.71 (136.55) 18.94 (96.08) 155.11 (274.20) 
 
Illicit drug use2 46.0% (250) 42.4% (204) 73.0% (46) 
 
Alcohol dependence (0-7) 1 1.25 (1.54) 1.11 (1.39) 2.32 (2.15) 
 
Alcohol use consequences (0-9) 1 2.00 (2.06) 1.84 (1.94) 3.21 (2.49) 
Mental, social, and health issues 
 
  
 
Depression (0-50) 1 10.69 (9.62) 9.53 (8.28) 19.59 (13.73) 
 
Mental health composite scale (0-100) 1 43.74 (10.19) 44.35 (9.89) 39.03 (11.31) 
 
Physical health composite scale (0-100) 1 51.76 (6.76) 52.18 (6.47) 48.58 (8.09) 
 
Health consequences (0-8) 1 2.93 (2.10) 1.95 (1.75) 2.79 (2.35) 
 
Social consequences (0-9) 1 2.05 (1.85) 2.77 (1.92) 4.19 (2.53) 
Socio-demographic characteristics 
 
  
 
Age1 20.10 (1.37) 20.05 (1.28) 20.53 (1.95) 
 
Language2 
 
  
  
French-speaking 51.8% (282) 52.4% (252) 47.6& (30) 
  
German-speaking 48.2% (262) 47.6% (229) 52.4% (33) 
 
Level of education2 
 
  
  
Lower secondary 49.4% (269) 49.1% (236) 52.41% (33) 
  
Upper secondary 25.7% (140) 25.8% (124) 25.4% (16) 
  
Tertiary 24.8% (135) 25.2% (121) 22.2% (14) 
 
Parents' level of education2 
 
  
  
Lower secondary 6.3% (34) 5.8% (28) 9.5% (6) 
  
Upper secondary 34.4% (187) 35.6% (171) 25.4% (16) 
  
Tertiary 59.4% (323) 58.6% (282) 65.1% (41) 
 
Perceived family income2 
 
  
  
Below average 15.8% (86) 37.8% (182) 30.2% (19) 
  
Average 36.9% (201) 47.4% (228) 46.0% (29) 
    Above average 47.2% (257) 14.8% (71) 23.8% (15) 
 
Table 1. Participants’ characteristics and comparison of concurrent versus simultaneous alcohol 
and NMUPD users 
1Mean and standard deviation under brackets are given. 
2N and percentages under brackets are given. The columns’ percentages are given for concurrent and simultaneous 
users, e.g., 73% of simultaneous users used illicit drugs, whereas 42.4% of concurrent users did so. 
  
17 
 
 
 
 
 
Concurrent users    Simultaneous users  Likelihood ratio Chi-
square 
p-
value   Mean 95% CI 
 
Mean 95% CI 
Alcohol dependence (0-7)1 1.12 0.99-1.27 
 
1.92 1.56-2.36 23.94 < .001 
Alcohol use consequences (0-9)1 1.71 1.54-1.91 
 
2.50 2.10-2.98 17.89 < .001 
Depression (0-50)1 10.25 9.85-10.47 
 
19.17 17.93-20.50 281.27 < .001 
Mental health composite scale (0-100)2 44.03 42.69-45.37 
 
39.44 36.74-42.13 10.80 .006 
Physical health composite scale (0-100)2 52.22 51.31-53.14 
 
48.87 47.03-50.71 12.30 < .001 
Health consequences (0-8)1 1.89 1.71-2.09 
 
2.39 2.00-2.86 6.53 .011 
Social consequences (0-9)1 2.70 2.49-2.94 
 
3.51 3.03-4.07 11.75 .007 
Table 2. Results of generalized linear models comparing concurrent versus simultaneous users of 
alcohol and NMUPD 
Remarks: The analysis was performed controlling for volume of drinking, frequency of NMUPD, language, level of 
education, parents’ level of education, perceived family income, age, and illicit drug use. Estimated marginal mean 
for volume of drinking = 11.04, frequency of NMUPD = 34.71, and age = 20.10 (mean scores) are given. 
1Count outcomes (Poisson regression), 2 linear outcomes (linear regression). 
A Holm-Bonferroni correction was applied. 
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